Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To identify factors that predict medication adherence and to examine relationships among adherence, glycemic control, and indices of insulin action in TODAY (Treatment Options for Type 2 Diabetes in Adolescents and Youth). RESEARCH DESIGN AND METHODS: A total of 699 youth 10–17 years old with recent-onset type 2 diabetes and ≥80% adherence to metformin therapy for ≥8 weeks during a run-in period were randomized to receive one of three treatments. Participants took two study pills twice daily. Adherence was calculated by pill count from blister packs returned at visits. High adherence was defined as taking ≥80% of medication; low adherence was defined as taking <80% of medication. Depressive symptoms, insulin sensitivity (1/fasting insulin), insulinogenic index, and oral disposition index (oDI) were measured. Survival analysis examined the relationship between medication adherence and loss of glycemic control. Generalized linear mixed models analyzed trends in adherence over time. RESULTS: In this low socioeconomic cohort, high and low adherence did not differ by sex, age, family income, parental education, or treatment group. Adherence declined over time (72% high adherence at 2 months, 56% adherence at 48 months, P < 0.0001). A greater percentage of participants with low adherence had clinically significant depressive symptoms at baseline (18% vs. 12%, P = 0.0415). No adherence threshold predicted the loss of glycemic control. Longitudinally, participants with high adherence had significantly greater insulin sensitivity and oDI than those with low adherence. CONCLUSIONS: In the cohort, the presence of baseline clinically significant depressive symptoms was associated with subsequent lower adherence. Medication adherence was positively associated with insulin sensitivity and oDI, but, because of disease progression, adherence did not predict long-term treatment success.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, individuals with EOT2D experience unique challenges in adhering to medication and lifestyle therapies compared to older adults [18,19,76,77,111].”
From Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions (2025) · cites this paper as [77]
In the citing paper
“These findings highlight the potential for intensive lifestyle interventions to drive short-term improvements in diabetes outcomes, while also underscoring the challenge of sustaining those benefits over the long term [76,77].”
From Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions (2025) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799
Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572 · cited 1×
“power to that of clamp DI for the 2-h glucose concentration of the oral glucose tolerance test (19,20).”
BackgroundMiller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
Long-Term Complications and Mortality in Young-Onset Diabetes
Constantino, M. I., Molyneaux, L., Limacher-Gisler, F., Al-Saeed, A., Luo, C., Wu, T., Twigg, S. M., Yue, D. K., & Wong, J. (2013) · Diabetes Care · doi:10.2337/dc12-2455 · Cited by 423
Lawrence, J. M., Standiford, D. A., Loots, B., Klingensmith, G. J., Williams, D. E., Ruggiero, A., Liese, A. D., Bell, R. A., Waitzfelder, B. E., McKeown, R. E., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-1398 · Cited by 329 · cited 1×
“lar to those reported in the SEARCH study (22), which found that being female and of older age were risk factors for higher rates of clinically significant de-”
BackgroundTODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288 · cited 1×
“is associated with faster deterioration in glycemic control (33) as well as insulin secretion (34).”
BackgroundDiabetes in Non-Hispanic White Youth
Bell, R. A., Mayer-Davis, E. J., Beyer, J. W., D'Agostino, R. B., Lawrence, J. M., Linder, B., Liu, L. L., Marcovina, S. M., Rodriguez, B. L., Williams, D., et al. (2009) · Diabetes Care · doi:10.2337/dc09-s202 · Cited by 209
Self-citationDiabetes in African American Youth
Mayer-Davis, E. J., Beyer, J., Bell, R. A., Dabelea, D., D'Agostino, R., Imperatore, G., Lawrence, J. M., Liese, A. D., Liu, L., Marcovina, S., et al. (2009) · Diabetes Care · doi:10.2337/dc09-s203 · Cited by 180
Self-citation
Cited by
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Vluggen, S., Candel, M., Hoving, C., Schaper, N. C., & de Vries, H. (2021) · Journal of Medical Internet Research · doi:10.2196/18524 · Cited by 26
Pinhas-Hamiel, O., & Hamiel, D. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01345-5 · Cited by 24
Management of Early-Onset Type 2 Diabetes in Adults: Current Evidence and Future Directions
Savage, M. J., Goldney, J., Slater, T., Sarkar, P., Sargeant, J. A., Wilmot, E. G., & Davies, M. J. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0561 · Cited by 11
Metadata
- Authors
- Katz, L. L., Anderson, B. J., McKay, S. V., Izquierdo, R., Casey, T. L., Higgins, L. A., Wauters, A., Hirst, K., Nadeau, K. J., & for the TODAY Study Group
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-06-28
- Volume
- 39
- Issue
- 11
- Pages
- 1956-1962
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2472552917
- Cited by
- 72
- References
- 9
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.